Testosterone acetate thiosemicarbazone (TATSC, 17-13-hydroxyandrost-4-one acetate thiosemicarbazone) was synthesized and characterized by single crystal X-ray structure determination. The copper and platinum complexes of this steroid derivative were synthesized and characterized by spectroscopy and electrochemiatry. The in vitro activity of these compounds against human breast cancer cell line MCF-7 was tested. The highest activity was found for the [Pt(TATSC)CI2] followed by [Cu(TATSC)CI2] and the ligand in compariosn with cisplatin.
Introduction
Transporting a cytotoxic drug selectively to the malignant cells without damaging the cells of the host organism is the desirable goal in the drug design for anticancer therapy. This task is made difficult because the morphological and biochemical differences between the malignant and normal cells are often minute. However, the presence of steroid hormone receptors found in high concentration in malignant cells of breast, ovary and prostate than in most of the normal cells offer excellent olportunities for such selective targeting by attaching a cytotoxic drug to the receptor binding carrier molecules. The cytotoxic agents that have so far been linked in such a manner include nitrosoureas, 24 nitrogen mustards, 2'5 epoxides, aziridines, DNA intercalators and platinum complexes. 6"!3 In the present paper we report the synthesis and molecular structure of new steroidal cisplatin conjufates and a preliminary evaluation of their antiproliferative activity against human breast cancer cell line, viz. MCF-7.
Experimental
All the chemicals used in the synthesis of ligand and its metal complexes were of AR grade. Solvents used in the synthesis and spectroscopic studies were distilled prior to their use.
Testosterone acetate (Sigma Chemicals), K2PtCI4 (John Baker, USA), CuCI2.2H20 (Qualigens), thiosemicarbazide (CDH) were used as supplied. Cisplatin was a gift from Dr. Kasabekar. Thiosemicarbazide hydrochloride was prepared by adding ml of concentrated hydrochloric acid to a slurry of 1.1 g of powdered thiosemicarbazide in ethanol. The white precipitate was isolated by filtration with adequate washings with cold ethanol and water to remove excess acid. It was recrystallized from water and used after drying in vacuum at room temperature.
Testosteroneacetate thiosemicarbazone (TATSC) For the synthesis of the thiosemicarbazone ligand, 1.0 g of testosterone acetate (TA) was dissolved in acetone to which was added 0.39 g TSC.HCI in a 1" molar ratio dissolved in minimum amount of distilled water. The resulting reaction mixture was heated at 60C with constant stirring for 6-8 hr during which the colour of the mixture changed from colourless to intense yellow. After completion of the reaction the solvent was stripped off on the rotavapor till yellow crystalline TATSC separated out. It was washed with cold water and dried in vacuum. All attempts to grow crystals suitable for single crystal X-ray structure determination via a normal diffractometer were unsuccessful. A crystal suitable for X-ray diffraction studies via high intensity synchrotron radiation was grown as pale yellow plate grown from acetonitrile solvent by slow evaporation.
Metal Complexes
These were prepared by reacting the ligand TATSC and corresponding metal chlorides in a 1:1 molar ratio in acetonitrile solvent at 40C with constant stirring for 8 hr. K2PtCI4 was used as the satrting material in the synthesis of the platinum complex whereas the copper complex was synthesized using CuCI.2H20. X-ray crystal structure determination"
The measurements were made on a Bruker AXS SMART CCD area detector diffractometer at Station 9.8 of the CLRC Daresbury Laboratory synchrotron radiation source. 4 The data was collected 5 Table 3 shows a summary of crystal data and X-ray analysis information for TATSC and the selected bond lengths and bond angles are listed in Table 4 .
The structure was solved by direct methods. 16 Hydrogen atoms showed clearly on difference Fourier maps. Anticancer Activity Assay
The MCF-7 human breast adinocarcinoma cell line was obtained from the National Centre for Cell Science (NCCS), Pune. The cells were cultured as monolayers and maintained in a growth medium (Eagles' Minimum Essential Medium (MEM(E))) consisting of MEM(E) supplemented with 10% FCS, 50g/ml streptomycin and 50 lag/ml glutamin. Stock cultures were harvested from 25 cm disposable tissue culture treated flasks and maintained in the incubator with a constant humidified atmosphere of 5% CO2 and 95% air at 37C.
The stock solutions of TATSC and its copper and platinum complexes were prepared as lmg/ml solutions in DMSO, filtered through 0.22 lam filters and stored in bottles at 8C. The 0.5 mg/ml stock solution of cisplatin was made in normal saline, filtered and stored at 8C. A neutral red solution was prepared by dissolving mg neutral red (NR) in 20 ml of MEM(E), warmed and centrifuged at 90 g for 10 rain for removing any neutral red crystals before filtration. De-staining solution was prepared with 1% acetic acid, 50% ethanol and 49% distilled water v/v according to an established protocol. 9 A Spectrochem-250 ELISA reader was used to read the final absorbances.
Before performing the neutral red assay, a preliminary range finding analysis of the potential toxicity of the test compounds was conducted wherein the highest tolerated dose (HTD) was defined as the highest concentration of the compound that is tolerated by the cells with minimal alterations in the morphology. For this analysis, the cells were seeded in 24-well plate at a density of 2 x 105 cells/ml. After 24 hr incubation, 100 1 of the medium was removed from each well except control and to each sample (in triplicate), 100 tl of the test compound (at different concentrations) was added. Quantitation of the viable cells was carried out by direct counting with a hemocytometer using trypan blue after 24 and 48 hours.
Since the active compounds were cytotoxic even at the concentration of 0.1 mg/ml, a much lower concentrationrgange was explored and the cell viability was determined by a neutral red assay using a 96 well plate method.
Results and Discussion
The analytical data including elemental analyses, electronic transitions and redox potentials of the complexes is given in Table 1 . All the complexes are found to be diamagnetic at room temperature.
The assignment of the significant vibrational bands of the ligand and its metal complexes are reported in Table 2 . The IR spectrum of testosterone acetate thiosemicarbazone (TATSC) exhibits absorption bands at 3425 and 3245 cm due to symmetric and asymmetric v(NH) stretching vibrations which are shifted to the higher frequency side on metal complexation. The C(3) C=O frequency in TA was replaced by C=N on condensation with thiosemicarbazone pharmacophore. Other absorptions which are affected upon complex formation include those due to v(N-N) stretch at 1053 cm and the v(C=N) stretch at 1587 cm t indicating the involvement of the azomethine nitrogen in metal coordination. The assignment of the bands involving the C=S group is uncertain and difficult due to its mixing with other frequencies over a wide range (1300-700 -I -2021 cm ).
Unaltered frequencies on complexaton are assigned to the methyl group (carbon portion) of the steroidal nucleus (2920 cm and the acetate group at C-17 position (1730 cm) respectively. S (1) C (20) N (3) N (2) N (1) C (4) C (3) C (5) C (6) C (2) C (19) C (10) C (9) C (11) C(12) C (7) C (18) C (14) C ( Figure 1 . Crystallographic details of the two compounds are given in Table 3 while selected bond distances and bond angles are listed in Table 4 (3)) are comparable with those observed in other E isomers. The observation that metal complexation results in the transformation of the E isomer into the Z configuration with enhanced biological activity suggest that such EZ conversion might be crucial for the biological effects of the thiosemicarbazone ligands.
All the synthesized compounds were tested on human breast cancer cell line, MCF-7 which showed comparable cytotoxicity at identical concentration (Figure 2) as the standard cisplatin compound. For the TATSC ligand an increase in the cytotoxicity was observed on metal complexation which can be explained on the basis of conversion to the preferred Z configuration. Thiosemicarbazone pharmacophores are known to inhibit DNA synthesis via inhibition of the enzyme RDR and to inflict DNA damages. These aspects are under investigation presently.
